Edgewise Therapeutics (EWTX) announced the appointment of Michael Nofi, as CFO, effective November 10. Nofi joins Edgewise after serving as Chief Accounting Officer at SpringWorks Therapeutics. Nofi will succeed Edgewise CFO, Michael Carruthers, who is retiring.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EWTX:
- Edgewise Therapeutics Reports Q3 2025 Financial Results
- Edgewise Therapeutics reports Q3 EPS (39c), consensus (40c)
- Edgewise Therapeutics price target raised to $33 from $30 at JPMorgan
- Edgewise Therapeutics Advances with Phase 1 Study of EDG-15400
- Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study